Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕HDFC Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹666.3420₹16.4070
NAV date20 Nov 202620 Nov 2026
History13.9 years4.0 years
Expense ratio1.0%1.1%
Stars★★★★★★★★★★
Growth Score75.2050.50

Returns

Nippon India Pharma FundHDFC Business Cycle Fund
1 month+11.40%+7.69%
3 months+3.74%+1.91%
6 months+8.55%+11.83%
YTD+16.94%+7.72%
1 year+15.26%+5.98%
3 years (CAGR)+17.96%+12.01%
5 years (CAGR)+15.40%—
10 years (CAGR)+16.61%—
Since launch+17.63%+13.24%

Risk

Nippon India Pharma FundHDFC Business Cycle Fund
Volatility14.1%15.5%
Downside volatility9.0%10.3%
Sharpe0.810.36
Sortino1.280.53
Calmar1.220.67
Return / risk1.270.78
Deepest fall−24.02%−18.04%
Days to recover445133
Below its high+0.00%+0.00%

Against benchmark

Nippon India Pharma FundHDFC Business Cycle Fund
Alpha−1.86%+0.41%
Beta0.890.92
R²89.5%90.6%
Up capture85.2%95.3%
Down capture88.7%92.0%
Tracking error4.8%4.9%
Information ratio−0.69−0.01
Treynor0.120.05

Consistency

Nippon India Pharma FundHDFC Business Cycle Fund
Best 1-year+90.70%+39.99%
Middle 1-year+13.13%+6.68%
Worst 1-year−15.12%−6.17%
1-year periods with a loss23.2%9.1%
Middle 3-year+19.82%+12.75%
Positive months63.9%61.1%
Best day+3.40%+4.12%
Worst day−3.21%−6.25%
Worst 5% day−1.38%−1.52%
Positive days53.7%54.9%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC Business Cycle Fund
5-year XIRR+18.24%—
5-year value₹9,54,076—
3-year XIRR+14.26%+8.57%
1-year XIRR+22.08%+15.07%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth